BSE filing, NSE: IBULLSLTD. Summary written from the filing by ALFA Finder's alert engine.
Indiabulls Ltd: key numbers
- Share price
- ₹31.88
- Market cap
- ₹7,435 Cr
- Revenue (annual)
- ₹833.4 Cr
- Net profit (annual)
- ₹273.9 Cr
- P/E (TTM)
- 17.7×Sector 43.1×
- Promoter holding
- 32.87%-0.04% QoQ
- FII holding
- 13.42%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indiabulls Ltd
All →Indiabulls Other Announcement
Indiabulls Limited filed its shareholding pattern for the quarter ended September 30, 2026. This is a routine regulatory compliance filing.
Indiabulls Price Movement Clarification
Indiabulls Ltd replied to NSE's price-movement surveillance query, stating no undisclosed information exists. No material business event is communicated to the market.
Indiabulls Other Announcement
Employee Amiteshwar Choudhary sold shares worth Rs. 0.32 Crore via market sale. This is a routine PIT Regulation 7(2) disclosure.
- Value
- ₹0.32 Cr
Indiabulls Other Announcement
Indiabulls Limited has submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Indiabulls Regulatory Approval
Indiabulls Limited received a Certificate of Registration from the Reserve Bank of India to operate as a Core Investment Company.
- From
- Reserve Bank of India
Indiabulls Promoter Buying (Off-Market)
Phanes Limited, a promoter group entity, was allotted 22,52,50,000 convertible warrants in Indiabulls Limited. The preferential allotment increases the promoter group's potential stake on a diluted basis.
- Promoter stake change
- -0.01%
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.